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The Nutrition Labeling and Education Act (NLEA), which amended the Federal Food, Drug, and Cosmetic Act in 1990,
authorized the use of health claims that are based on signiﬁcant scientiﬁc agreement in food labeling. In 1994, the Dietary
Supplement Health and Education Act (DSHEA) deﬁned dietary supplements and created a legal framework for use of claims that
is similar to the regulation of foods. Health claims describe the relationship between a substance (food or food component) and
reduction of the risk of a disease or health-related condition; they are not intended as claims to cure, treat, mitigate, or prevent
disease, which are considered drug claims. Since the enactment of the NLEA, the FDA has developed a process to evaluate
scientiﬁc evidence in support of health claims. In 1999, the FDA published Guidance for Industry: Signiﬁcant Scientiﬁc Agreement
in the Review of Health Claims for Conventional Foods and Dietary Supplements. As a result of a series of court cases, the
agency developed a process for qualiﬁed health claims that characterizes the quality and strength of scientiﬁc evidence because
these claims are not based on signiﬁcant scientiﬁc agreement. Since 2003, the FDA has published several letters of enforcement
discretion for qualiﬁed health claims that illustrate the agency’s approach to evaluating the scientiﬁc literature when the strength
of the evidence is not consistent with signiﬁcant scientiﬁc agreement.
In 2007, the agency published the draft Guidance for Industry: Evidence-Based Review System for the Scientiﬁc Evaluation
of Health Claims that further outlined the FDA’s approach to evaluating scientiﬁc evidence for health claims. In January 2009,
the ﬁnal guidance was posted and replaced the 1999 guidance document as well as the interim guidance related to qualiﬁed
health claims. The ﬁnal guidance speciﬁcally addresses the use of observational data in the evaluation of health claims and
describes the criteria used by the agency in the evaluation of such data. A copy of the guidance can be found on the FDA
Web site (http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodLabelingNutrition/
ucm073332.htm). The guidance highlights some of the challenges that must be considered for the agency to use observational
data to draw scientiﬁc conclusions on the relationship between a speciﬁc substance and disease or health-related condition for the
health claim under review.
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